Advertisement

Loading...

UBS Solactive China Technology UCITS ETF USD acc

CQQQ.SWSIX
NaN
NaN
CHF7.78
CHF0.21(2.79%)
Swiss Market opens in 4h 45m

UBS Solactive China Technology UCITS ETF USD acc Fundamental Analysis

UBS Solactive China Technology UCITS ETF USD acc (CQQQ.SW) shows weak financial fundamentals with a PE ratio of 22.90, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.
We analyze CQQQ.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
0.0/100

We analyze CQQQ.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

CQQQ.SW struggles to generate sufficient returns from assets.

ROA > 10%
N/A

Valuation Score

Moderate

CQQQ.SW shows balanced valuation metrics.

PE < 25
22.90
PEG Ratio < 2
N/A

Growth Score

Moderate

CQQQ.SW shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

CQQQ.SW carries high financial risk with limited liquidity.

Debt/Equity < 1
N/A
Current Ratio > 1
N/A

Profitability Score

Weak

CQQQ.SW struggles to sustain strong margins.

ROE > 15%
N/A
Net Margin ≥ 15%
N/A
Positive Free Cash Flow
N/A

Key Financial Metrics

Is CQQQ.SW Expensive or Cheap?

P/E Ratio

CQQQ.SW trades at 22.90 times earnings. This indicates a fair valuation.

22.90

How Well Does CQQQ.SW Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How CQQQ.SW Stacks Against Its Sector Peers

MetricCQQQ.SW ValueSector AveragePerformance
P/E RatioN/A10.84 N/A
ROEN/A173.00% N/A
Net MarginN/A384.00% N/A
Debt/EquityN/A0.20 N/A
Current RatioN/A0.06 N/A
ROAN/A13.00% N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews UBS Solactive China Technology UCITS ETF USD acc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Blend, Diversified, Stable

EPS CAGR

N/A

Industry Style: Blend, Diversified, Stable

FCF CAGR

N/A

Industry Style: Blend, Diversified, Stable

Fundamental Analysis FAQ